Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:23 AM
Ignite Modification Date:
2025-12-25 @ 1:23 AM
NCT ID:
NCT00935493
Eligibility Criteria:
Inclusion Criteria:
Subjects enrolled will be nondemented, male and female individuals who meet the following inclusion criteria:
* 75 years of age or older
* Fluent in English
* Stable medical condition for at least 4 weeks prior to Screening visit
* Stable dose of non-excluded medications for at least 4 weeks prior to Screening visit
Exclusion Criteria:
* Dementia
* Mild Cognitive Impairment (Amnestic MCI)
* Clinically significant neurologic disease
* Clinically significant or unstable medical conditions that would interfere with participation in the trial
* Known hypersensitivity to guanfacine
* History of alcohol or substance abuse or dependence within the past 5 years
* Active major psychiatric disorders, including major depression
* History of mental retardation
* Significant abnormalities on clinical laboratories, ECG, or physical examination
* Impairment of visual or auditory acuity sufficient to interfere with completion of study procedures
* Education level \< 6 years
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
75 Years
Study:
NCT00935493
Study Brief:
Protocol Section:
NCT00935493